SCHEMBL7562710

SCHEMBL7562710

CCCC1CN([C]=O)CC(O)C1c1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 1/20 0.43
MDM2 Q00987 2/20 0.35
DRD2 P14416 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6042438 0.81 SLC6A3 (0.57) SLC6A3DRD2
SCHEMBL6042173 0.80 MDM2 (0.45) SLC6A3MDM2
SCHEMBL6953266 0.77 SLC6A3 (0.41) SLC6A3MDM2
SCHEMBL6951399 0.72 SLC6A3 (0.37) SLC6A3MDM2
SCHEMBL6041749 0.71 SLC6A3 (0.42) SLC6A3DRD2
SCHEMBL6042593 0.61 SLC6A3 (0.37) SLC6A3DRD2
SCHEMBL6041346 0.61 CCR1 (0.37) MDM2
SCHEMBL3827721 0.60 SLC6A3 (1.00) SLC6A3
SCHEMBL13679363 0.60 SLC6A3 (1.00) SLC6A3
SCHEMBL3827724 0.60 SLC6A3 (1.00) SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002076440-A2 METHODS OF TREATING ALZHEIMER'S DISEASE WITH PIPERIDIN DERIVATES ELAN PHARMACEUTICALS, INC. (US) 2002-10-03 WO disclosed